Back to Search
Start Over
Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers
- Source :
- The Journal of infection, Tré-Hardy, M, Cupaiolo, R, Papleux, E, Wilmet, A, Horeanga, A, Antoine-Moussiaux, T, Della Vecchia, A, Beukinga, I, Vekemans, M & Blairon, L 2021, ' Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers ', Journal of Infection, vol. 83, no. 2, pp. 237-279 . https://doi.org/10.1016/j.jinf.2021.03.025, The Journal of Infection
- Publication Year :
- 2021
-
Abstract
- SCOPUS: le.j<br />info:eu-repo/semantics/published
- Subjects :
- Microbiology (medical)
2019-20 coronavirus outbreak
COVID-19 Vaccines
Coronavirus disease 2019 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Article
Health personnel
Humans
Medicine
BNT162 Vaccine
Messenger RNA
Reactogenicity
business.industry
SARS-CoV-2
Vaccination
COVID-19
Généralités
Virology
Immunogenicity
immunogenicity, reactogenicity, safety, mRNA-1273 vaccine
mRNA-1273 vaccine
Infectious Diseases
Antibody response
Safety
business
Antibody formation
Immunogenicity, Reactogenicity, Safety, mRNA-1273 vaccine
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- The Journal of infection, Tré-Hardy, M, Cupaiolo, R, Papleux, E, Wilmet, A, Horeanga, A, Antoine-Moussiaux, T, Della Vecchia, A, Beukinga, I, Vekemans, M & Blairon, L 2021, ' Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers ', Journal of Infection, vol. 83, no. 2, pp. 237-279 . https://doi.org/10.1016/j.jinf.2021.03.025, The Journal of Infection
- Accession number :
- edsair.doi.dedup.....232e7f9dc65979a7adf5a7bb0c9b4252
- Full Text :
- https://doi.org/10.1016/j.jinf.2021.03.025